Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of lypressin tablet in China. Welcome to wholesale bulk high quality lypressin tablet for sale here from our factory. Good service and reasonable price are available.
Lypressin tablet, as an artificially synthesized peptide bioactive substance, has high specificity in molecular conformation and physiological activity. Its structural characteristics determine its precise clinical application orientation, and its application scenarios also show distinct targeting without redundant extension.
Its core application dimensions focus clearly on three points, namely the structural properties of its own nine peptide chain and its homologous association with natural antidiuretic substances, precise symptomatic intervention for central diabetes insipidus, and short-term effective control of mild bleeding symptoms. These three dimensions together constitute the core value system of its clinical application, and are also the key features that distinguish it from other peptide hormones.
Products Overview
lypressin COA
 |
||
| Certificate of Analysis | ||
| Compound name | lypressin | |
| Grade | Pharmaceutical grade | |
| CAS No. | 50-57-7 | |
| Quantity | Customized | |
| Packaging standard | Customized | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202501090065 | |
| MFG | Jan 9th 2026 | |
| EXP | Jan 8th 2029 | |
| Structure |  |
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.54% |
| Loss on drying | ≤1.0% | 0.42% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.98% |
| Single impurity | <0.8% | 0.52% |
| Total microbial count | ≤750cfu/g | 95 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 500ppm |
| Storage | Store in a sealed, dark, and dry place below -20°C | |
|
|
||
The structural characteristics and natural homology of the peptide chain of Lypressin
The core structural properties of lypressin tablet lay the foundation for its physiological activity, and its homology with natural antidiuretic substances determines its clinical applicability, which can be briefly analyzed from two aspects:Firstly, the core feature of peptide chain structure is that this substance belongs to a typical nine peptide active factor. The peptide chain sequence is composed of nine amino acids in an orderly series, with a stable molecular configuration that can maintain moderate biological activity in the body.
Compared with other peptide hormones, its structure is closer to natural antidiuretic related substances and has good biocompatibility.Secondly, it has a homologous relationship with natural antidiuretic substances, and its molecular structure is highly compatible with pig derived natural antidiuretic active substances. The core substance that dominates antidiuretic function in the human body is arginine vasopressin (AVP).The two have consistency in the core orientation of physiological functions, with only slight differences at specific sites in the amino acid sequence. This homology is also an important prerequisite for their ability to exert antidiuretic related effects.
Source of information:
The structural characteristics of lypressin and its homology with natural antidiuretic hormones
Symptomatic intervention mechanism and application points of Lypressin for central diabetes insipidus
The core pathological crux of central diabetes insipidus lies in the deficiency of antidiuretic function caused by abnormal central regulation. Lypressin tablet can alleviate the core symptoms of the disease through precise targeted intervention, and its application value can be explored from three aspects: mechanism, practice, and adaptability.
The core texture of targeted intervention. This substance can specifically act on the relevant receptors of the renal collecting duct, promote the reabsorption of water by the kidneys through mediating signaling pathways, reduce the generation and excretion of urine, and improve core symptoms such as polyuria and excessive thirst. Its target is precise and can directly compensate for the insufficient secretion of antidiuretic active substances in patients with central diabetes insipidus, achieving rapid symptom relief.Practical details of clinical application.
In clinical practice, the administration plan is mostly adjusted according to the severity of the patient's symptoms. For mild to moderate patients, local administration can be used.For severe patients, systemic administration can be combined to supplement. After administration, the patient's urine volume, water consumption and electrolyte level need to be closely monitored to avoid electrolyte disorder caused by water retention. At the same time, the dosage can be dynamically adjusted according to the improvement of symptoms.The core scenario of disease adaptation.
This intervention method is mainly suitable for long-term maintenance treatment of central diabetes insipidus, especially for patients with impaired secretion of antidiuretic hormone caused by abnormal hypothalamic pituitary axis function.It can effectively replace the function of natural antidiuretic substances, help patients restore normal water metabolism balance, reduce life troubles caused by polyuria and excessive thirst, and at the same time, for some secondary central diabetes insipidus, it can be used as an auxiliary intervention method, combined with etiological treatment to improve efficacy.
Source of information:
Lypressin in the temporary control of mild bleeding: a clinical analysis
The application effect of lysine vasopressin in short-term management of mild esophageal variceal bleeding
Application characteristics of Lypressin in short-term management of mild bleeding
Lypressin tablet has mild procoagulant activity and can be used as a temporary control measure for mild bleeding, especially for specific types of bleeding symptoms. Its application details can be analyzed from three aspects: mechanism of action, adaptation scenarios, and usage precautions:
Firstly, the core mechanism of short-term hemostasis is that this substance can activate relevant coagulation factors in the body, promote the contraction and repair of endothelial cells, enhance the coagulation ability of local blood vessels, and moderately increase blood viscosity to accelerate the formation of blood clots, thereby achieving rapid control of mild bleeding.
Its hemostatic effect is mild and short-lived, suitable for temporarily relieving bleeding symptoms.
Secondly, the appropriate types and scenarios of bleeding are mainly used in clinical practice for mild bleeding caused by esophageal varices. This type of bleeding is mostly caused by small amounts of bleeding due to venous rupture. Lypressin can quickly control bleeding symptoms by constricting venous vessels, promoting coagulation, and buying time for targeted treatment in the future; It can also be used for mild outflow control in patients with von Willebrand disease, which belongs to hereditary coagulation factor deficiency and is prone to spontaneous mild bleeding. Lypressin can assist in enhancing coagulation factor activity and relieving bleeding symptoms.
Thirdly, the core precautions during use are that this substance is only suitable for temporary control of mild bleeding and cannot be used for the rescue of severe bleeding or active massive bleeding. The dosage should be strictly controlled during use to avoid adverse reactions such as vascular embolism caused by excessive coagulation. At the same time, the administration method should be adjusted according to the patient's coagulation function. For patients with severe coagulation dysfunction, the hemostatic effect will be significantly affected, and other hemostatic methods should be used in combination.
Source of information:
The effect of lysine vasopressin on coagulation factor activity and exploration of hemostatic mechanism
Lypressin: structural properties and clinical application in bleeding control and diabetes insipidus
In summary, the unique nine peptide chain structure of lypressin tablet and its high homology with natural antidiuretic substances form the core foundation for its physiological activity and clinical application. This structure and homology advantage not only endow the substance with good biocompatibility and targeting, but also enable it to accurately meet the intervention needs of clinical related diseases, providing solid molecular and pharmacological support for subsequent clinical applications. In the temporary management of mild bleeding, relying on mild procoagulant activity, rapid and safe short-term blood control can be achieved for specific scenarios such as esophageal varices and von Willebrand disease, saving valuable time for subsequent etiological treatment.
These two clinical application scenarios fully demonstrate their core advantages of precise targeting, mild effectiveness, and strong adaptability, distinguishing them from other similar peptide substances. In the actual clinical application process, it is necessary to strictly follow relevant physiological indicators, develop personalized usage plans, reasonably control the dosage and method of administration, avoid adverse reactions caused by improper use, and fully realize its clinical application value. It also provides more reliable and accurate technical support and treatment pathways for clinical interventions of central diabetes insipidus and mild bleeding related diseases, helping to standardize clinical diagnosis and treatment work.
References
Analysis of the Nine Peptide Structure and Biological Activity of Lysine Vasopressin
Clinical observation of lypressin in the treatment of central diabetes insipidus
Clinical intervention of central diabetes insipidus and the application value of lysine vasopressin
Von Willebrand disease: mild bleeding management with lypressin
FAQ
Lypressin is primarily used in medical applications to treat conditions such as diabetes insipidus and certain types of bleeding disorders. Its mechanism of action involves binding to vasopressin receptors in the kidneys, promoting water reabsorption and concentrating urine.
Adults: lypressin spray (diapid) contains contains approximately 0.007 mg lypression per spray. (equivalent to 2 Posterior Pituitary Units). For treatment of diabetes insipidus, 1-2 sprays should be administered in each nostril 4 times daily.
Side effects include rhinorrhea, nasal congestion, irritation, nasal ulceration, headache, conjunctivitis, heartburn, periorbital edema, chest tightness, and dyspnea.
Lypressin is a hormone used to prevent or control the frequent urination, increased thirst, and loss of water associated with diabetes insipidus (water diabetes). Its molecular weight is 1056.2 Dalton having an amino acid sequence of Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2. The Molecular Formula is: C46H65N13O12S2.
Hot Tags: lypressin tablet, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale